These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25762349)

  • 1. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.
    Rong G; Wang H; Bowlus CL; Wang C; Lu Y; Zeng Z; Qu J; Lou M; Chen Y; An L; Yang Y; Gershwin ME
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):132-41. PubMed ID: 25762349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
    Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis.
    Caballería L; Parés A; Castells A; Ginés A; Bru C; Rodés J
    Am J Gastroenterol; 2001 Apr; 96(4):1160-3. PubMed ID: 11316164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
    Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
    Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
    Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
    World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
    Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
    World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers.
    Cavazza A; Caballería L; Floreani A; Farinati F; Bruguera M; Caroli D; Parés A
    Hepatology; 2009 Oct; 50(4):1162-8. PubMed ID: 19585656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Suzuki A; Lymp J; Donlinger J; Mendes F; Angulo P; Lindor K
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):259-64. PubMed ID: 17174610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
    Trivedi PJ; Lammers WJ; van Buuren HR; Parés A; Floreani A; Janssen HL; Invernizzi P; Battezzati PM; Ponsioen CY; Corpechot C; Poupon R; Mayo MJ; Burroughs AK; Nevens F; Mason AL; Kowdley KV; Lleo A; Caballeria L; Lindor KD; Hansen BE; Hirschfield GM;
    Gut; 2016 Feb; 65(2):321-9. PubMed ID: 25567117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan.
    Harada K; Hirohara J; Ueno Y; Nakano T; Kakuda Y; Tsubouchi H; Ichida T; Nakanuma Y
    Hepatology; 2013 May; 57(5):1942-9. PubMed ID: 23197466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
    Floreani A; Baragiotta A; Baldo V; Menegon T; Farinati F; Naccarato R
    Hepatology; 1999 May; 29(5):1425-8. PubMed ID: 10216125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Silveira MG; Suzuki A; Lindor KD
    Hepatology; 2008 Oct; 48(4):1149-56. PubMed ID: 18785621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).
    Floreani A; Biagini MR; Chiaramonte M; Milani S; Surrenti C; Naccarato R
    Ital J Gastroenterol; 1993; 25(9):473-6. PubMed ID: 8123893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Tomiyama Y; Takenaka K; Kodama T; Kawanaka M; Sasaki K; Nishina S; Yoshioka N; Hara Y; Hino K
    Intern Med; 2013; 52(14):1553-9. PubMed ID: 23857086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
    Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
    J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.